Sven M Francque (Sven Francque, S M Francque)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 45

Top Venues

The New England journal of medicine

Nature reviews. Gastroenterology & hepatology

United European gastroenterology journal

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Christos Lionis, Sophia Papadakis, Marilena Anastasaki, Eftihis Aligizakis, Foteini Anastasiou, Sven M Francque, Irini Gergianaki, Juan Manuel Mendive, Maria E Marketou, Jean W M Muris, Spilios Manolakopoulos, Georgios Papatheodoridis, Dimitrios Samonakis, Emmanouil Symvoulakis, Ioanna Tsiligianni
Practice Recommendations for the Management of MASLD in Primary Care: Consensus Results. Diseases (Basel, Switzerland) 12 (8) (2024)
Jing Zeng, Jian-Gao Fan, Sven M Francque
Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European gastroenterology journal (2024)
Michael P Cooreman, Javed Butler, Robert P Giugliano, Faiez Zannad, Lucile Dzen, Philippe Huot-Marchand, Martine Baudin, Daniel R Beard, Jean-Louis Junien, Pierre Broqua, Manal F Abdelmalek, Sven M Francque
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis. Nature communications 15 (1) (2024)
Juan Manuel Pericàs, Quentin Mark Anstee, Salvador Augustin, Ramon A Bataller, Annalisa Berzigotti, Andreea Ciudin, Sven M Francque, Juan G Abraldes, Virginia Hernández-Gea, Mònica Pons, Thomas Reiberger, Denis Moir, Peter Rydqvist, Elmer Schabel, Frank Tacke, Emmanuel A Tsochatzis, Joan Genescà
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis. Nature reviews. Gastroenterology & hepatology (2024)
Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Jonathan Mertens, Laurence Roosens, Rie Braspenning, Joeri Vandebeeck, Sven M Francque, Christophe E M De Block
The 13C glucose breath test accurately identifies insulin resistance in people with type 1 diabetes. The Journal of clinical endocrinology and metabolism (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
Michael P Cooreman, Javed Butler, Robert P Giugliano, Faiez Zannad, Lucile Dzen, Philippe Huot-Marchand, Martine Baudin, Daniel R Beard, Jean-Louis Junien, Pierre Broqua, Manal F Abdelmalek, Sven M Francque
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis. Nature communications 15 (1) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Jing Zeng, Jian-Gao Fan, Sven M Francque
Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European gastroenterology journal 12 (2) (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
Michael P Cooreman, Javed Butler, Robert P Giugliano, Faiez Zannad, Lucile Dzen, Philippe Huot-Marchand, Martine Baudin, Daniel R Beard, Jean-Louis Junien, Pierre Broqua, Manal F Abdelmalek, Sven M Francque
The pan-PPAR agonist lanifibranor improves cardiometabolic health in patients with metabolic dysfunction-associated steatohepatitis. Nature communications 15 (1) (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Jing Zeng, Jian-Gao Fan, Sven M Francque
Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European gastroenterology journal 12 (2) (2024)
Christos Lionis, Sophia Papadakis, Marilena Anastasaki, Eftihis Aligizakis, Foteini Anastasiou, Sven M Francque, Irini Gergianaki, Juan Manuel Mendive, Maria E Marketou, Jean W M Muris, Spilios Manolakopoulos, Georgios Papatheodoridis, Dimitrios Samonakis, Emmanouil Symvoulakis, Ioanna Tsiligianni
Practice Recommendations for the Management of MASLD in Primary Care: Consensus Results. Diseases (Basel, Switzerland) 12 (8) (2024)
Matthew McTeer, Douglas Applegate, Peter Mesenbrink, Vlad Ratziu, Jörn M Schattenberg, Elisabetta Bugianesi, Andreas Geier, Manuel Romero Gomez, Jean-Francois Dufour, Mattias Ekstedt, Sven M Francque, Hannele Yki-Jarvinen, Michael Allison, Luca Vittorio Valenti, Luca Miele, Michael Pavlides, Jeremy Cobbold, Georgios Papatheodoridis, Adriaan G Holleboom, Dina Tiniakos, Clifford Brass, Quentin Mark Anstee, Paolo Missier, null null
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information. PloS one 19 (2) (2024)
Jing Zeng, Jian-Gao Fan, Sven M Francque
Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European gastroenterology journal 12 (2) (2024)
Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Sven M Francque, Alexander Hodge, Jérôme Boursier, Ziad H Younes, Gerardo Rodriguez-Araujo, Grace S Park, Naim Alkhouri, Manal F Abdelmalek
Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (2) (2024)
Emma Vanderschueren, Angelo Armandi, Wilhelmus Josephus Kwanten, David Cassiman, Sven M Francque, Jörn Markus Schattenberg, Wim Laleman
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease. The American journal of gastroenterology 119 (8) (2024)
Jing Zeng, Jian-Gao Fan, Sven M Francque
Therapeutic management of metabolic dysfunction associated steatotic liver disease. United European gastroenterology journal 12 (2) (2024)
Juan Manuel Pericàs, Quentin Mark Anstee, Salvador Augustin, Ramon A Bataller, Annalisa Berzigotti, Andreea Ciudin, Sven M Francque, Juan G Abraldes, Virginia Hernández-Gea, Mònica Pons, Thomas Reiberger, Denis Moir, Peter Rydqvist, Elmer Schabel, Frank Tacke, Emmanuel A Tsochatzis, Joan Genescà
A roadmap for clinical trials in MASH-related compensated cirrhosis. Nature reviews. Gastroenterology & hepatology (2024)
Stephen A Harrison, Pierre Bedossa, Cynthia D Guy, Jörn Markus Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E Moussa, Guy W Neff, Mary E Rinella, Quentin M Anstee, Manal F Abdelmalek, Zobair M Younossi, Seth J Baum, Sven M Francque, Michael R Charlton, Philip Noel Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M Pericàs, Rashmee Patil, Arun J Sanyal, Mazen Noureddin, Meena B Bansal, Naim Alkhouri, Laurent Castera, Madhavi Rudraraju, Vlad Ratziu, null null
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis. The New England journal of medicine 390 (6) (2024)
Emma Vanderschueren, Angelo Armandi, Wilhelmus Josephus Kwanten, David Cassiman, Sven M Francque, Jörn Markus Schattenberg, Wim Laleman
Spleen Stiffness-Based Algorithms Are Superior to Baveno VI Criteria to Rule Out Varices Needing Treatment in Patients With Advanced Chronic Liver Disease. The American journal of gastroenterology (2024)
Christos Lionis, Sophia Papadakis, Marilena Anastasaki, Eftihis Aligizakis, Foteini Anastasiou, Sven M Francque, Irini Gergianaki, Juan Manuel Mendive, Maria E Marketou, Jean W M Muris, Spilios Manolakopoulos, Georgios Papatheodoridis, Dimitrios Samonakis, Emmanouil Symvoulakis, Ioanna Tsiligianni
Practice Recommendations for the Management of MASLD in Primary Care: Consensus Results. Diseases (Basel, Switzerland) 12 (8) (2024)
Juan Manuel Pericàs, Quentin Mark Anstee, Salvador Augustin, Ramon A Bataller, Annalisa Berzigotti, Andreea Ciudin, Sven M Francque, Juan G Abraldes, Virginia Hernández-Gea, Mònica Pons, Thomas Reiberger, Denis Moir, Peter Rydqvist, Elmer Schabel, Frank Tacke, Emmanuel A Tsochatzis, Joan Genescà
A roadmap for clinical trials in MASH-related compensated cirrhosis. Nature reviews. Gastroenterology & hepatology (2024)
Kris V Kowdley, Christopher L Bowlus, Cynthia Levy, Ulus S Akarca, Mario Reis Alvares-da-Silva, Pietro Andreone, Marco Arrese, Christophe Corpechot, Sven M Francque, Michael A Heneghan, Pietro Invernizzi, David Jones, Frederik C Kruger, Eric Lawitz, Marlyn J Mayo, Mitchell L Shiffman, Mark G Swain, José Miguel Valera, Victor Vargas, John M Vierling, Alejandra Villamil, Carol Addy, Julie Dietrich, Jean-Michel Germain, Sarah Mazain, Dragutin Rafailovic, Bachirou Taddé, Benjamin Miller, Jianfen Shu, Claudia O Zein, Jörn Markus Schattenberg, null null
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis. The New England journal of medicine (2023)
Stan Driessen, Sven M Francque, Stefan D Anker, Manuel Castro Cabezas, Diederick E Grobbee, Maarten E Tushuizen, Adriaan Georgius Holleboom
Metabolic dysfunction-associated steatotic liver disease and the heart. Hepatology (Baltimore, Md.) (2023)
Sven M Francque
Towards precision medicine in non-alcoholic fatty liver disease. Reviews in endocrine & metabolic disorders (2023)
Emily Taillieu, De Witte Chloë, Heiko De Schepper, Wouter Van Moerkercke, Sophie Rutten, Stijn Michiels, Yuna Arnst, Sofie De Bruyckere, Sven M Francque, Frauke van Aert, Christophe George, Emma Callewaert, Tiene Callewaert, Glenn Vanneste, Erik Vanderstraeten, Nina Van Heddegem, Margaux Vansteelant, Koen Chiers, Freddy Haesebrouck, Christophe Van Steenkiste
Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease. Alimentary pharmacology & therapeutics (2023)
Abraham S Meijnikman, Mark Davids, Hilde Herrema, Ömrüm Aydin, Valentina Tremaroli, Melany Rios-Morales, Han Levels, Sjoerd Bruin, Maurits de Brauw, Joanne Verheij, Ellis Marleen Kemper, Adriaan G Holleboom, Maarten E Tushuizen, Thue W Schwartz, Jens Nielsen, Dees Brandjes, Eveline Dirinck, Jonas Weyler, An Verrijken, Christophe E M De Block, Luisa Vonghia, Sven M Francque, Ulrich H W Beuers, Victor E A Gerdes, Fredrik Bäckhed, Albert K Groen, Max Nieuwdorp
Microbiome-derived ethanol in nonalcoholic fatty liver disease. Nature medicine 28 (10) (2022)
Audrey Deprince, Nathalie Hennuyer, Sander Kooijman, Amanda C M Pronk, Eric Baugé, Viktor Lienard, An Verrijken, Eveline Dirinck, Luisa Vonghia, Eloïse Woitrain, Niels J Kloosterhuis, Eléonore Marez, Pauline Jacquemain, Justina Clarinda Wolters, Fanny Lalloyer, Delphine Eberlé, Sandrine Quemener, Emmanuelle Vallez, Anne Tailleux, Mostafa Kouach, Jean-Francois Goossens, Violeta Raverdy, Bruno Derudas, Jan Albert Kuivenhoven, Mikaël Croyal, Bart van de Sluis, Sven M Francque, Francois Pattou, Patrick C N Rensen, Bart Staels, Joel T Haas
Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride-rich lipoprotein metabolism. Hepatology (Baltimore, Md.) (2022)
Mohammed Eslam, Hashem E El-Serag, Sven M Francque, Shiv Kumar Sarin, Lai Wei, Elisabetta Bugianesi, Jacob George
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nature reviews. Gastroenterology & hepatology 19 (10) (2022)
Sven M Francque, Vincent Wai-Sun Wong
NAFLD in lean individuals: not a benign disease. Gut (2021)
Sven M Francque, Pierre Bedossa, Vlad Ratziu, Quentin M Anstee, Elisabetta Bugianesi, Arun J Sanyal, Rohit Loomba, Stephen A Harrison, Rozalina Balabanska, Lyudmila Mateva, Nicolas Lanthier, Naim Alkhouri, Christophe Moreno, Jörn Markus Schattenberg, Diana Stefanova-Petrova, Luisa Vonghia, Régine Rouzier, Maeva Guillaume, Alexander Hodge, Manuel Romero-Gómez, Philippe Huot-Marchand, Martine Baudin, Marie-Paule Richard, Jean-Louis Abitbol, Pierre Broqua, Jean-Louis Junien, Manal F Abdelmalek, null null
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH. The New England journal of medicine 385 (17) (2021)
Jeffrey Victor Lazarus, Henry E Mark, Quentin Mark Anstee, Juan Pablo Arab, Rachel L Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M Ashworth Dirac, Sven M Francque, Jacob George, Hannes Hagström, Terry T K Huang, Mona H Ismail, Achim Kautz, Shiv Kumar Sarin, Stephen Caldwell, Veronica Miller, Philip N Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero, Jörn Markus Schattenberg, Emmanuel A Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M Younossi, Shira Zelber-Sagi, null null
Advancing the global public health agenda for NAFLD: a consensus statement. Nature reviews. Gastroenterology & hepatology (2021)
Jonel Trebicka, Wenyi Gu, Victor de Ledinghen, Christophe Aubé, Aleksander Krag, Michael Praktiknjo, Laurent Castera, Jerome Dumortier, David Josef Maria Bauer, Mireen Friedrich-Rust, Stanislas Pol, Ivica Grgurevic, Rongqin Zheng, Sven M Francque, Halima Gottfriedovà, Sanda Mustapic, Ioan Sporea, Annalisa Berzigotti, Frank Erhard Uschner, Benedikt Simbrunner, Maxime Ronot, Christophe Cassinotto, Maria Kjaergaard, Filipe Andrade, Martin Schulz, Georg Semmler, Ida Tjesic Drinkovic, Johannes Chang, Maximilian Joseph Brol, Pierre Emmanuel Rautou, Thomas Vanwolleghem, Christian P Strassburg, Jérôme Boursier, Philip Georg Ferstl, Ditlev Nytoft Rasmussen, Thomas Reiberger, Valerie Vilgrain, Aymeric Guibal, Olivier Guillaud, Stefan Zeuzem, Camille Vassord, Xue Lu, Luisa Vonghia, Renata Senkerikova, Alina Popescu, Cristina Margini, Wenping Wang, Maja Sofie Thiele, Chrisitan Jansen
Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease. Gut (2021)
Paolo Zanoni, Grigorios Panteloglou, Alaa Othman, Joel T Haas, Roger Meier, Antoine Rimbert, Marta Futema, Yara Abou-Khalil, Simon Flyvbjerg Nørrelykke, Andrzej Rzepiela, Szymon Stoma, Michael Stebler, Freerk van Dijk, Melinde Wijers, Justina C Wolters, Nawar Dalila, Nicolette Huijkman, Marieke Smit, Antonio Gallo, Valerie Carreau, Anne Philippi, Jean-Pierre Rabès, Catherine Boileau, Michele Visentin, Luisa Vonghia, Jonas Weyler, Sven M Francque, An Verrijken, Ann Verhaegen, Luc F Van Gaal, Adriaan van der Graaf, Belle V van Rosmalen, Jérôme Robert, Srividya Velagapudi, Mustafa Yalcinkaya, Michaela Keel, Silvija Radosavljevic, Andreas Geier, Anne Tybjærg-Hansen, Mathilde Varret, Lucia Rohrer, Steve E Humphries, Bart Staels, Bart van de Sluis, Jan Albert Kuivenhoven, Arnold Von Eckardstein
Posttranscriptional Regulation of the Human LDL Receptor by the U2-Spliceosome. Circulation research (2021)
Sven M Francque, Gyongyi Szabo, Manal F Abdelmalek, Christopher D Byrne, Kenneth Cusi, Jean-François Dufour, Michael Roden, Frank Sacks, Frank Tacke
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors. Nature reviews. Gastroenterology & hepatology 18 (1) (2020)
Wim Verlinden, Eugénie Van Mieghem, Laura Depauw, Thomas Vanwolleghem, Luisa Vonghia, Jonas Weyler, Ann Driessen, Dirk Callens, Laurence Roosens, Eveline Lia Dirinck, An Verrijken, Luc Van Gaal, Sven M Francque
Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis. Biomedicines 8 (12) (2020)
Ning Liang, Anastasius Damdimopoulos, Saioa Goñi, Zhiqiang Huang, Lise-Lotte Vedin, Tomas Jakobsson, Marco Giudici, Osman Ahmed, Matteo Pedrelli, Serena Barilla, Fawaz Alzaid, Arturo Mendoza, Tarja Schröder, Raoul Kuiper, Paolo Parini, Anthony Hollenberg, Philippe Lefebvre, Sven M Francque, Luc Van Gaal, Bart Staels, Nicolas Venteclef, Eckardt Treuter, Rongrong Fan
Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα. Nature communications 10 (1) (2019)
Denise Van der Graaff, Wilhelmus J Kwanten, Filip J Couturier, Jesse S Govaerts, Wim Verlinden, Isabel Brosius, Michiel D'Hondt, Ann Driessen, Benedicte Y De Winter, Joris G De Man, Peter P Michielsen, Sven M Francque
Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats. Laboratory investigation; a journal of technical methods and pathology 98 (10) (2018)
C H De Fré, M A De Fré, Wilhelmus Josephus Kwanten, B J Op de Beeck, L F Van Gaal, Sven M Francque
Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity? Obesity reviews : an official journal of the International Association for the Study of Obesity 20 (2) (2018)

Sven M Francque.css-eqlu8i{font-size:small;padding-left:4px;} (Sven Francque, S M Francque)

Publication Activity (10 Years)

Top Topics

Top Venues

Sven M Francque (Sven Francque, S M Francque)